Emerging drugs of abuse in Connecticut

Connecticut Medicine

Volumn 64, Issue 1, 2000, Pages 19-23

  Weiner, Alan L ^a,b,c  

^a MidState Medical Center   (United States)

^b TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Department of Medical Toxicology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 HYDROXYBUTYRIC ACID; KETAMINE; METHYLPHENIDATE;

DRUG ABUSE; DRUG INFORMATION; HUMAN; INTERNET; MORBIDITY; MORTALITY; REVIEW; UNITED STATES;

CANNABIS; CONNECTICUT; FEMALE; HUMANS; INCIDENCE; KETAMINE; MALE; METHYLPHENIDATE; RISK ASSESSMENT; SODIUM OXYBATE; SUBSTANCE-RELATED DISORDERS;

EID: 0033950972     PISSN: 00106178     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (21)

1. Hoffman RS, Goldfrank LR: The impact of drug abuse and addiction on society. Emerg Med Clinics North America 1990; 8:467-80.
2. Dalgarno PJ, Shewan D: Illicit use of ketamine in Scotland. J Psychoactive Drugs 1996; 28:191-9.
3. Hirota K, Lambert DG: Ketamine: Its mechanism of action and unusual clinical uses (ed). Brit J Anesth 1996; 77:441-4.
4. Anonymous: DEA to control "Special K" for the first time. Drug Enforcement Administration (DEA) Press Release. 13 July 1999.
5. VieiraL, Weiner AL: Ketamine abusers presenting to the emergency department (abstract). Clin Tox 1998; 36:505.
6. Anonymous: State warns of date rape drug. Hartford Courant 16 June 1999, B3.
7. Taylor FG: "Party" drug claims a victim. Hartford Courant 22 May 1999, pp A1, A24.
8. Chin RL, Sporer KA, Cullison B, et al: Clinical course of gamma-hydroxybutyrate intoxication. Ann Emerg Med 1998; 31:716-22.
9. Centers for Disease Control: Multistate outbreak of poisoning associated with illicit use of gamma-hydroxybutyrate. JAMA 1991; 265:447-8.
10. Ropero-Miller JD, Goldberger BA: Recreational drugs: Current trends in the nineties. Clin Lab Med 1998; 18:727-46.
11. Kohrs FP, Porter WH: Gamma-hydroxybutyrate intoxication and overdose (letter). Ann Emerg Med 1999; 33:475-6.
12. Anonymous: From the Centers for Disease Control and Prevention. Adverse effects associated with ingestion of gamma butyrolactone 1998-1999. JAMA 1999; 281:979-980.
13. Food and Drug Administration: FDA warns about products containing gamma butyrolactone (GBL) and asks companies to issue a recall. FDA Bulletin 21 January 1999.
14. Massello W, Carpenter DA: A fatality due to the intranasal abuse of methylphenidate. J Forensic Sci 1999; 44:220-1.
15. Anonymous: Methylphenidate. DEA Press Release 20 October 1995.
16. Garland EJ: Intranasal abuse of prescribed methylphenidate. J Am Acad Child Adolesc Psychiatry 1998; 37:573-4.
17. Albertson TE, Van Hoozen BE, Allen RP: Amphetamines. In Haddad LM, Shannon MW, Winchester JF (eds): Clinical Management of Poisoning and Drug Overdose, 3rd edition. WB Saunders: Philadelphia, Penn; 1988:560-8.
18. Nelson LS, Holland JA, Ravikumar PR. Dangerous forms of marijuana (lett). Ann Emerg Med 1999; 34:115-116.
19. Elwood WN: "Fry": A study of adolescents, use of embalming fluid with marijuana and tobacco. Texas Commision on Alcohol and Drug Abuse: Austin Texas, 1998.
20. Holland JA, Nelson LS, Ravikumar PR, et al: Embalming fluid soaked marijuana: New high or new guise for PCP? J Psychoactive Drugs 1998; 30:215-9.
21. Borrero M: Illy: Dangerous new street drug. Hartford Courant 3 January 1996, A9.